Home › Gastrointestinal Stromal Tumors
Gastrointestinal Stromal Tumors clinical trials recruiting in the U.S.
19 studies for Gastrointestinal Stromal Tumors are recruiting participants at sites across the United States.
Cities with the most studies
- Miami, FL8 studies
- Boston, MA7 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- New York City, NY6 studies
- San Diego, CA5 studies
- Nashville, TN5 studies
- Portland, OR5 studies
- Omaha, NE5 studies
- Durham, NC4 studies
- Akron, OH4 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Rochester, MN4 studies
- Cleveland, OH4 studies
- Ann Arbor, MI4 studies
- Chicago, IL4 studies
- Seattle, WA4 studies
- Jacksonville, FL4 studies
- Washington, DC4 studies
- Birmingham, AL3 studies
- Salt Lake City, UT3 studies
- Cedar Rapids, IA3 studies
- Tampa, FL3 studies
- Aurora, CO3 studies
- St. Louis, MO3 studies
- San Francisco, CA3 studies
- Baltimore, MD3 studies
- Santa Monica, CA3 studies
- Columbus, OH3 studies
By state
- Alabama3 studies
- Arizona4 studies
- California11 studies
- Colorado5 studies
- Connecticut4 studies
- Florida11 studies
- Illinois6 studies
- Iowa4 studies
- Kansas3 studies
- Maryland6 studies
- Massachusetts9 studies
- Michigan7 studies
- Minnesota6 studies
- Missouri5 studies
- Nebraska5 studies
- New York8 studies
- North Carolina6 studies
- Ohio10 studies
- Oregon5 studies
- Pennsylvania6 studies
- Tennessee7 studies
- Texas7 studies
- Utah3 studies
- Washington4 studies
- Wisconsin4 studies
Recently updated studies
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
RecruitingObservational study
Ages 6 and older · All sexes · Updated Oct 2, 2026 · NCT04557969A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06760819DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07218926A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07585266Imatinib TDM in GIST
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05493215KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07406633A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05957367LRG GIST Patient Registry
RecruitingObservational study
All ages · All sexes · Updated Jul 13, 2026 · NCT07697248Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT05208047Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT07171203PH 2 Pemigatinib in SDH-deficient GIST
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT07434843A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06630234A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06655246Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT01048281A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT06805825ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05366816From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.